NCT00718588View on ClinicalTrials.gov

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis

PHASE1TerminatedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2009

Conditions

Rheumatoid Arthritis

Interventions

DRUG

MTRX1011A

Subcutaneous and intravenous single and repeating dose

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY